SCHEMBL12932322

SCHEMBL12932322

COc1cccc(NC(=O)NC2CCC(OCc3c(F)cccc3F)CC2)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 5/20 0.69
▸ RAB9A P51151 6/20 0.64
▸ NPC1 O15118 4/20 0.64
▸ MEN1 O00255 3/20 0.64
▸ KMT2A Q03164 3/20 0.64
▸ MAPT P10636 2/20 0.64
▸ PKM P14618 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ USP2 O75604 1/20 0.49
▸ ALDH1A1 P00352 3/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ NFKB1 P19838 1/20 0.47
▸ CASP3 P42574 1/20 0.47
▸ NFKB2 Q00653 1/20 0.47
▸ RELA Q04206 1/20 0.47
▸ SENP8 Q96LD8 1/20 0.47
▸ SENP7 Q9BQF6 1/20 0.47
▸ SENP6 Q9GZR1 1/20 0.47
▸ CCR3 P51677 1/20 0.47
▸ CXCR3 P49682 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3190106 1.00 EPHX2 (0.69) EPHX2RAB9ANPC1MEN1KMT2A
SCHEMBL3182568 0.90 EPHX2 (0.63) EPHX2RAB9ANPC1MEN1KMT2A
SCHEMBL3182573 0.90 EPHX2 (0.63) EPHX2RAB9ANPC1MEN1KMT2A
SCHEMBL3188291 0.88 EPHX2 (0.72) EPHX2RAB9ANPC1MEN1KMT2A
SCHEMBL3188296 0.88 EPHX2 (0.72) EPHX2RAB9ANPC1MEN1KMT2A
SCHEMBL3182153 0.87 EPHX2 (0.74) EPHX2RAB9ANPC1MEN1KMT2A
SCHEMBL3182145 0.87 EPHX2 (0.74) EPHX2RAB9ANPC1MEN1KMT2A
SCHEMBL3178470 0.86 EPHX2 (0.72) EPHX2RAB9ANPC1MEN1KMT2A
SCHEMBL3178477 0.86 EPHX2 (0.72) EPHX2RAB9ANPC1MEN1KMT2A
SCHEMBL3172705 0.85 EPHX2 (0.72) EPHX2RAB9ANPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8476043-B2 Inhibitors for the soluble epoxide hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-07-02 — — US disclosed
US-8476043-B2 Inhibitors for the soluble epoxide hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-07-02 — — US disclosed
US-20110021448-A1 Inhibitors for the Soluble Epoxide Hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-01-27 — — US disclosed
US-20110021448-A1 Inhibitors for the Soluble Epoxide Hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-01-27 — — US disclosed
US-7662910-B2 Inhibitors for the soluble epoxide hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-02-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021448-A1 Inhibitors for the Soluble Epoxide Hydrolase EPHX1, EPHX2, NCEH1 EPHX2 2/4885RAB9A 3525/4885NPC1 778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback